Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Colm Bergin and Gerry Hughes.
Colm Bergin
Connection Strength
1.708
Gerry Hughes
  1. Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing. Clin Infect Dis. 2021 07 15; 73(2):351-352.
    View in: PubMed
    Score: 0.956
  2. SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months. Ir J Med Sci. 2021 Jul 07.
    View in: PubMed
    Score: 0.239
  3. Prevalence of smell and taste dysfunction in a cohort of CoVID19 outpatients managed through remote consultation from a large urban teaching hospital in Dublin, Ireland. Infect Prev Pract. 2020 Sep; 2(3):100076.
    View in: PubMed
    Score: 0.223
  4. Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity. Viruses. 2021 07 15; 13(7).
    View in: PubMed
    Score: 0.060
  5. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. Epidemiol Infect. 2021 06 08; 149:e140.
    View in: PubMed
    Score: 0.059
  6. Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic. J Antimicrob Chemother. 2021 01 01; 76(1):272-275.
    View in: PubMed
    Score: 0.058
  7. Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC Antimicrob Resist. 2020 Dec; 2(4):dlaa095.
    View in: PubMed
    Score: 0.057
  8. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC Antimicrob Resist. 2020 Sep; 2(3):dlaa071.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.